Profiel
Tim Clark is former Chair of the T1D Fund Investment Committee and former member of JDRF’s International Board of Directors.
He and his wife, Tara, have been active in JDRF since 2007 when their daughter Melissa was diagnosed with T1D at the age of 12.
Tim is the former CIO of CarVal Investors, a global alternative investment manager and a subsidiary of Cargill.
Currently, he is the President and CEO of TreeHouse, a faith-based mentoring organization focused on empowering vulnerable youth.
Prior to joining TreeHouse, he was the CEO of Urban Ventures, an inner city non-profit providing multi-cultural holistic family, education, and employment programming.
Tim received his M.B.A.
with a specialization in Finance from the University of Chicago and a B.A.
in Economics and Psychology from DePauw University.
He is a certified public accountant.
Actieve functies van Clark Tim
| Bedrijven | Functie | Begin |
|---|---|---|
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Voorzitter | - |
Eerdere bekende functies van Clark Tim
| Bedrijven | Functie | Einde |
|---|---|---|
| Urban Ventures Leadership Foundation | Algemeen Directeur | - |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Directeur/Bestuurslid | - |
CarVal Investors GB LLP
 CarVal Investors GB LLP Investment ManagersFinance CarVal Investors GB LLP (CarVal GB) is an alternative asset manager headquartered in London, UK. The firm was founded in 1987 and is a subsidiary of CarVal Investors UK Ltd., which is owned by CarVal Investors Management LP in the US. CarVal GB provides investment advice to high-net worth individuals and investment professionals. | Chief Investment Officer | - |
Opleiding van Clark Tim
| The University of Chicago | Masters Business Admin |
| DePauw University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
CarVal Investors GB LLP
CarVal Investors GB LLP Investment ManagersFinance CarVal Investors GB LLP (CarVal GB) is an alternative asset manager headquartered in London, UK. The firm was founded in 1987 and is a subsidiary of CarVal Investors UK Ltd., which is owned by CarVal Investors Management LP in the US. CarVal GB provides investment advice to high-net worth individuals and investment professionals. | Finance |
| Urban Ventures Leadership Foundation | Health Services |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Commercial Services |
